ici 204,219 has been researched along with Obstructive Lung Diseases in 2 studies
zafirlukast: a leukotriene D4 receptor antagonist
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was designed to evaluate the bronchodilating role of zafirlukast, a CysLT(1)receptor antagonist, at the standard dosage currently recommended in the marketing of this agent in smokers with COPD." | 2.69 | Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist. ( Allegra, L; Boveri, B; Carlucci, P; Cazzola, M; Centanni, S; DiMarco, F; Santus, P, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nathan, RA | 1 |
| Bernstein, JA | 1 |
| Bielory, L | 1 |
| Bonuccelli, CM | 1 |
| Calhoun, WJ | 1 |
| Galant, SP | 1 |
| Hanby, LA | 1 |
| Kemp, JP | 1 |
| Kylstra, JW | 1 |
| Nayak, AS | 1 |
| O'Connor, JP | 1 |
| Schwartz, HJ | 1 |
| Southern, DL | 1 |
| Spector, SL | 1 |
| Williams, PV | 1 |
| Cazzola, M | 1 |
| Boveri, B | 1 |
| Carlucci, P | 1 |
| Santus, P | 1 |
| DiMarco, F | 1 |
| Centanni, S | 1 |
| Allegra, L | 1 |
2 trials available for ici 204,219 and Obstructive Lung Diseases
| Article | Year |
|---|---|
Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.
Topics: Adolescent; Adult; Aged; Asthma; Bronchodilator Agents; Child; Double-Blind Method; Female; Humans; | 1998 |
Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist.
Topics: Aged; Albuterol; Anti-Asthmatic Agents; Area Under Curve; Bronchodilator Agents; Cross-Over Studies; | 2000 |